Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer.

Yan, Yan; Lin, Hong-Wei; Zhuang, Zhuo-Nan; Li, Ming; Guo, Sen

Yan, Yan; Lin, Hong-Wei; Zhuang, Zhuo-Nan; Li, Ming; Guo, Sen.

Afiliación

Yan Y; Department of Operating Room, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China.
Lin HW; Department of Gastrointestinal Surgery, Beijing Tsinghua Changgung Hospital School of Clinical Medicine, Tsinghua University, Beijing 102200, China.
Zhuang ZN; Department of Gastrointestinal Surgery, Beijing Tsinghua Changgung Hospital School of Clinical Medicine, Tsinghua University, Beijing 102200, China.
Li M; Department of General Surgery, Zouping Traditional Chinese Medicine Hospital, Zhouping 256200, Shandong Province, China.
Guo S; Department of General Surgery, Qilu Hospital, Shandong University, Jinan 250012, Shandong Province, China. guosen4321@163.com.

World J Gastrointest Oncol ; 12(8): 877-892, 2020 Aug 15.

Article en En | MEDLINE | ID: mdl-32879665

Palabras clave

Chemotherapy; Colon carcinoma; Fluorouracil; Interleukin-1; Nuclear factor kappa-B; Proliferation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Gastrointest Oncol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google